Read More Pharma Industry News How the TIGeR-PaC sub-study could influence future thinking around chemotherapy tolerability and precision delivery RenovoRx’s TIGeR-PaC sub-study highlights how targeted chemotherapy delivery could reshape pancreatic cancer treatment strategy. Read more. bySoujanya RaviMay 28, 2026